QuickView for immunoglobulin m

1. Treatment of human Non-Hodgkins Lymphoma cell lines with agonistic antibodies
2. B-cell lymphoma SUDHL4 cells stimulated with both megaCD40L and IgM/G
3. B-cell development stages - hematopoietic stem cells, progenitor B-cells and mature B-cells
4. DLBCL U-2932 cells expressing RC3H2 wildtype or RC3H2 Y691F mutation and treated with F(ab')2-IgM
5. Drug target sets for approved compounds

PubMedClientImpl.search() failed to connect to SOLR server.

1. Immunoglobulin M (IgM)-Anti-myelin-associated-glycoprotein(MAG) Peripheral Neuropathy Study
2. Point of Care Evaluation of Novir 2019-nCoV Immunoglobulin G/ Immunoglobulin M (IgG/IgM) Antibody Te…
3. Idelalisib for Immunoglobulin M (IgM)-Associated Primary (AL) Amyloidosis
4. Immunglobulin M Enriched Intra Venous Immunoglobulin (IVIG) Therapy in Adult Respiratory Distress Sy…
5. Intravenous Immunoglobulin for PANDAS